Prevalence of hypertension mediated organ damage in subjects with high-normal blood pressure without known hypertension as well as cardiovascular and kidney disease.


Journal

Journal of human hypertension
ISSN: 1476-5527
Titre abrégé: J Hum Hypertens
Pays: England
ID NLM: 8811625

Informations de publication

Date de publication:
07 2022
Historique:
received: 24 05 2021
accepted: 26 08 2021
revised: 21 08 2021
pubmed: 9 9 2021
medline: 20 7 2022
entrez: 8 9 2021
Statut: ppublish

Résumé

Purpose of our study was to assess the prevalence of hypertension mediated organ damage (HMOD) in healthy subjects with high-normal Blood Pressure (BP) comparing them with subjects with BP values that are considered normal (<130/85 mmHg) or indicative of hypertension (≥140/90 mmHg). Seven hundred fifty-five otherwise healthy subjects were included. HMOD was evaluated as pulse wave velocity (PWV), left ventricular mass index (LVMI), and carotid intima-media thickness (IMT) and plaque. When subjects were classified according to BP levels we found that the high-normal BP group showed intermediate values of PWV and higher values of IMT. This corresponds to intermediate prevalence of arterial stiffness, while there were no differences for increased IMT or carotid plaque. No subjects showed left ventricular hypertrophy. At multivariable analysis, the odds of having arterial stiffness or carotid HMOD in the high-normal group resulted not different to the normal group. In conclusion, in our otherwise healthy population, high-normal BP values were not related to aortic, carotid or cardiac HMOD.

Identifiants

pubmed: 34493835
doi: 10.1038/s41371-021-00604-6
pii: 10.1038/s41371-021-00604-6
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

610-616

Subventions

Organisme : EC | EC Seventh Framework Programm | FP7 Ideas: European Research Council (FP7-IDEAS-ERC - Specific Programme: "Ideas" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013))
ID : 278249
Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research)
ID : PREMIA

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39:3021–104.
doi: 10.1093/eurheartj/ehy339
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.
doi: 10.1097/HJH.0b013e3281fc975a
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–219.
doi: 10.1093/eurheartj/eht151
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JJ, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–72.
doi: 10.1001/jama.289.19.2560
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e426–83.
pubmed: 30354655
Kokubo Y, Kamide K. High-normal blood pressure and the risk of cardiovascular disease. Circ J. 2009;73:1381–5.
doi: 10.1253/circj.CJ-09-0336
Huang Y, Wang S, Cai X, Mai W, Hu Y, Tang H, et al. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med. 2013;11:177.
doi: 10.1186/1741-7015-11-177
Thomopoulos C, Parati G, Zanchetti A. Effects of blood-pressure-lowering treatment on outcome incidence. 12. Effects in individuals with high-normal and normal blood pressure: overview and meta-analyses of randomized trials. J Hypertens. 2017;35:2150–60.
doi: 10.1097/HJH.0000000000001547
Materson BJ, Garcia-Estrada M, Degraff SB, Preston RA. Prehypertension is real and can be associated with target organ damage. J Am Soc Hypertens. 2017;11:704–8.
doi: 10.1016/j.jash.2017.09.005
Delles C. Risk factors and target organ damage: is there a special case for prehypertension? J Hypertens. 2008;26:2268–70.
doi: 10.1097/HJH.0b013e328317f039
Booysen HL, Norton GR, Maseko MJ, Libhaber CD, Majane OH, Sareli P, et al. Aortic, but not brachial blood pressure category enhances the ability to identify target organ changes in normotensives. J Hypertens. 2013;31:1124–30.
doi: 10.1097/HJH.0b013e328360802a
Norton GR, Maseko M, Libhaber E, Libhaber CD, Majane OH, Dessein P, et al. Is prehypertension an independent predictor of target organ changes in young-to-middle-aged persons of African descent? J Hypertens 2008;26:2279–87.
doi: 10.1097/HJH.0b013e328311f296
Cuspidi C, Sala C, Tadic M, Gherbesi E, Facchetti R, Grassi G, et al. High-normal blood pressure and abnormal left ventricular geometric patterns: a meta-analysis. J Hypertens. 2019;37:1312–9.
doi: 10.1097/HJH.0000000000002063
Cuspidi C, Sala C, Tadic M, Gherbesi E, Grassi G, Mancia G. Pre-hypertension and subclinical cardiac damage: A meta-analysis of echocardiographic studies. Int J Cardiol. 2018;270:302–8.
doi: 10.1016/j.ijcard.2018.06.031
Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM. Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens. 2011;13:332–42.
doi: 10.1111/j.1751-7176.2011.00471.x
Cuspidi C, Sala C, Tadic M, Gherbesi E, Grassi G, Mancia G. Pre-hypertension and subclinical carotid damage: a meta-analysis. J Hum Hypertens. 2019;33:34–40.
doi: 10.1038/s41371-018-0114-6
Lewandowski J, Artyszuk Ł, Ostrowski F, Ciszewski J, Puchalska L, Abramczyk P. Individuals with high-normal blood pressure have different metabolic and haemodynamic characteristics to those with optimal blood pressure. Kardiol Pol. 2012;70:252–8.
pubmed: 22430405
Toikka JO, Laine H, Ahotup M, Haapanen A, Viikari JS, Hartiala JJ, et al. Increased arterial intima‐media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension. 2000;36:929–33.
doi: 10.1161/01.HYP.36.6.929
Grassi G, Buzzi S, Dell’Oro R, Mineo C, Dimitriadis K, Seravalle G, et al. Structural alterations of the retinal microcirculation in the “prehypertensive” high-normal blood pressure state. Curr Pharm Des. 2013;19:2375–81.
doi: 10.2174/1381612811319130005
Knight EL, Kramer HM, Curhan GC. High-normal blood pressure and microalbuminuria. Am J Kidney Dis. 2003;41:588–95.
doi: 10.1053/ajkd.2003.50120
Washio M, Tokunaga S, Yoshimasu K, Kodama H, Liu Y, Sasazuki S, et al. Role of prehypertension in the development of coronary atherosclerosis in Japan. J Epidemiol. 2004;14:57–62.
doi: 10.2188/jea.14.57
Lehmann N, Erbel R, Mahabadi AA, Kälsch H, Möhlenkamp S, Moebus S, et al. Accelerated progression of coronary artery calcification in hypertension but also prehypertension. J Hypertens. 2016;34:2233–42.
doi: 10.1097/HJH.0000000000001080
Maloberti A, Farina F, Carbonaro M, Piccinelli E, Bassi I, Pansera F, et al. In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers. Blood Press. 2018;27:262–70.
doi: 10.1080/08037051.2018.1461010
Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Modification of Diet in Renal Disease - Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766–72.
doi: 10.1373/clinchem.2006.077180
The Reference Values for Arterial Stiffness’ Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J. 2010;31:2338–50.
doi: 10.1093/eurheartj/ehq165
Bruno RM, Cartoni G, Stea F, Armenia S, Bianchini E, Buralli S, et al. Carotid and aortic stiffness in essential hypertension and their relation with target organ damage: the CATOD study. J Hypertens. 2017;35:310–8.
doi: 10.1097/HJH.0000000000001167
Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977;55:613–8.
doi: 10.1161/01.CIR.55.4.613
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–70.
doi: 10.1093/ehjci/jev014
Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, Ghali JK. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol. 1997;29:641–7.
doi: 10.1016/S0735-1097(96)00552-9
Maloberti A, Meani P, Varrenti M, Giupponi L, Stucchi M, Vallerio P, et al. Structural and Functional Abnormalities of Carotid Artery and Their Relation with EVA Phenomenon. High Blood Press Cardiovasc Prev. 2015;22:373–9.
doi: 10.1007/s40292-015-0100-9
Engelen L, Ferreira I, Stehouwer CD, Boutouyrie P, Laurent S. Reference Values for Arterial Measurements Collaboration. Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J. 2013;34:2368–80.
doi: 10.1093/eurheartj/ehs380
Touboul P-J, Hennerici M, Meairs S, Adams H, Amarenco P, Desvarieux M, et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis. 2004;18:346–9.
doi: 10.1159/000081812
Bajpai JK, Sahay AP, Agarwal AK, De AK, Garg B, Goel A. Impact of prehypertension on left ventricular structure, function and geometry. J Clin Diagn Res. 2014;8:BC07–10.
pubmed: 24959434 pmcid: 4064896
Li T, Yang J, Guo X, Chen S, Sun Y. Geometrical and functional changes of left heart in adults with prehypertension and hypertension: a cross-sectional study from China. BMC Cardiovasc Disord. 2016;16:114.
doi: 10.1186/s12872-016-0286-3
Cuspidi C, Facchetti R, Bombelli M, Tadic M, Sala C, Grassi G, et al. High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population. Hypertension. 2019;73:612–9.
doi: 10.1161/HYPERTENSIONAHA.118.12114
Meani P, Maloberti A, Sormani P, Colombo G, Giupponi L, Stucchi M, et al. Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up. Blood Press. 2018;27:32–40.
doi: 10.1080/08037051.2017.1378069
Cuspidi C, Negri F, Muiesan ML, Capra A, Lonati L, Milan A, et al. Working Group on Heart and Hypertension, Italian Society of Hypertension. Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice. Blood Press. 2011;20:3–9.
doi: 10.3109/08037051.2010.514713
Huang LC, Lin RT, Chen CF, Chen CH, Juo SH, Lin HF. Predictors of Carotid Intima-Media Thickness and Plaque Progression in a Chinese Population. J Atheroscler Thromb. 2016;23:940–9.
doi: 10.5551/jat.32177
Muiesan ML, Pasini G, Salvetti M, Calebich S, Zulli R, Castellano M, et al. Cardiac and vascular structural changes. Prevalence and relation to ambulatory blood pressure in a middle-aged general population in northern Italy: the Vobarno Study. Hypertension. 1996;27:1046–52.
doi: 10.1161/01.HYP.27.5.1046

Auteurs

Alessandro Maloberti (A)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy. alessandro.maloberti@ospedaleniguarda.it.
University of Milano-Bicocca, Milan, Italy. alessandro.maloberti@ospedaleniguarda.it.

Paola Rebora (P)

Bicocca Center of Bioinformatics, Biostatistics and Bioimaging (B4 center), School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Giuseppe Occhino (G)

Bicocca Center of Bioinformatics, Biostatistics and Bioimaging (B4 center), School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Marta Alloni (M)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.

Francesco Musca (F)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.

Oriana Belli (O)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.

Francesca Spano (F)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.

Gloria Maria Santambrogio (GM)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.

Lucia Occhi (L)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.

Benedetta De Chiara (B)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.

Francesca Casadei (F)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.

Antonella Moreo (A)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.

Maria Grazia Valsecchi (MG)

Bicocca Center of Bioinformatics, Biostatistics and Bioimaging (B4 center), School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Cristina Giannattasio (C)

Cardiology IV, "A.De Gasperis" Department, ASTT GOM Niguarda Ca' Granda, Milan, Italy.
University of Milano-Bicocca, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH